
Diabetes Prevention Between RAAS Inhibition and PPAR‐Gamma Stimulation: The Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Trial
Author(s) -
McFarlane Samy I.,
Provilus Alfrede,
Shin John J.
Publication year - 2007
Publication title -
journal of the cardiometabolic syndrome
Language(s) - English
Resource type - Journals
eISSN - 1559-4572
pISSN - 1559-4564
DOI - 10.1111/j.1559-4564.2007.06663.x
Subject(s) - medicine , diabetes mellitus , prediabetes , rosiglitazone , impaired fasting glucose , metformin , impaired glucose tolerance , acarbose , ramipril , type 2 diabetes , endocrinology , blood pressure